Clinical Trial Update: H-22411: BOTOX® for Peyronie's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for BOTOX for Peyronie's Disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peyronie Disease

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Mohit Khera | Conditions: Peyronie's Disease | Phase 2 | Status: COMPLETED | Results posted: 2020-02-17